United States: MannKind Announces Up To $200 Million Royalty Purchase Agreement With Sagard Healthcare - Cooley LLP

United States: MannKind Announces Up To $200 Million Royalty Purchase Agreement With Sagard Healthcare - Cooley LLP

Mondaq

Published

Pursuant to a license agreement with United Therapeutics, MannKind is entitled to a 10% royalty on net sales of Tyvaso DPI, subject to certain reductions.

Full Article